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Abstract
Background: Genome wide association studies (GWAS), mostly in Europeans have identified several common
variants as associated with key lipid traits. Replication of these genetic effects in South Asian populations is
important since it would suggest wider relevance for these findings. Given the rising prevalence of metabolic
disorders and heart disease in the Indian sub-continent, these studies could be of future clinical relevance.
Methods: We studied seven common variants associated with a variety of lipid traits in previous GWASs. The study
sample comprised of 3178 sib-pairs recruited as participants for the Indian Migration Study (IMS). Associations with
various lipid parameters and quantitative traits were analyzed using the Fulker genetic association model.
Results: We replicated five of the 7 main effect associations with p-values ranging from 0.03 to 1.97x10-7. We
identified particularly strong association signals at rs662799 in APOA5 (beta=0.18 s.d, p=1.97 x 10-7), rs10503669 in
LPL (beta =−0.18 s.d, p=1.0 x 10-4) and rs780094 in GCKR (beta=0.11 s.d, p=0.001) loci in relation to triglycerides. In
addition, the GCKR variant was also associated with total cholesterol (beta=0.11 s.d, p=3.9x10-4). We also replicated
the association of rs562338 in APOB (p=0.03) and rs4775041 in LIPC (p=0.007) with LDL-cholesterol and
HDL-cholesterol respectively.
Conclusions: We report associations of five loci with various lipid traits with the effect size consistent with the
same reported in Europeans. These results indicate an overlap of genetic effects pertaining to lipid traits across the
European and Indian populations.
Keywords: SNP, Fulker’s Association model and Lipid traits
Background
Cholesterol and triglycerides are major plasma lipids and
key heritable risk factors for cardiovascular disease [1,2].
Common genetic variations, environmental influences and
interaction effects between them can alter circulating
levels of plasma lipids. Genome wide association studies
(GWASs) have been instrumental in identification of sev-
eral single nucleotide polymorphisms (SNPs), which are
associated with altered plasma lipid levels. Evidence for a
role of these SNPs as mediators of variation in plasma
lipid levels in non-Europeans would demonstrate wider
relevance of GWAS findings. This could enhance the pos-
sibility of extending potential clinical benefits such as
identification of novel therapeutic agents and risk predic-
tion beyond populations in which GWASs were initially
performed [3]. More realistically such studies could iden-
tify novel associations at the known loci, due to variation
in linkage disequilibrium structure.
A recent genome wide meta-analysis under the Global
lipid genetics consortium, comprising over 100,000 European
individuals identified 95 loci as associated with at least one
of the three main lipid traits including low-density lipopro-
tein cholesterol (LDL-Cholesterol), high-density lipoprotein
cholesterol (HDL-Cholesterol) and triglycerides (TG) in
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individuals of Caucasian descent [4]. Follow up analysis in
9,705 South Asians residing in the UK (LOLIPOP-London
Life Sciences Prospective Population Study) identified a ma-
jority of SNP associations to be in the same direction as
reported in the Caucasian samples, yet a majority of the ini-
tial associations failed to replicate in the South Asian (4). As-
sociation studies are needed to replicate and establish the
true effect sizes of established variants for lipid traits in indi-
genous South Asian populations. It is known that the preva-
lence of metabolic syndrome in South Asians residing in
urban locations and developed countries [5,6] is higher when
compared to individuals from rural areas [7]. As such, associ-
ation studies conducted across the urban and rural Diasporas
within the sub-continent can generate more accurate esti-
mates of genetic effect sizes. In addition, the Indian popula-
tion is an amalgamation of distinct endogamous genetic sub
groups 9. The average population differentiation within 19
Indian sub populations was identified to be 3 fold greater
than that observed in a study of 23 European population
groups [8]. Hence, it is important to ensure that precautions
are taken to prevent false positive associations due to popula-
tion substructure, while conducting genetic association stud-
ies in the South Asian populations.
The primary analysis in this study aimed to replicate
associations of eight common genetic variants which are
known to be associated with key lipid traits in European
populations, in an indigenous Indian involving 3178 sib-
pairs from the Indian Migration Study (IMS). We stud-
ied the effect of variants in APOA5, APOB, APOE/CI/
C4, CETP, LDLR, GCKR, LPL, and LIPC on lipid traits
which included triglyceride levels, LDL-cholesterol,
HDL-cholesterol and total cholesterol (TC) levels. All
the SNPs that were selected for the present study have
been identified to be associated with lipid traits at gen-
ome wide significance in previous GWASs [4,9,10]. The
lipid trait associated with any of the studied loci at the
highest GWAS level of significance in European studies
was termed as the primary lipid trait for those loci.
Subsequent analysis also included investigation of the as-
sociation of loci with secondary lipid traits which may or
may not be associated with the studied variants in previ-
ous European studies. We also investigated the role of
gene-environment effects in influencing the primary trait
associations.
Results
A total of 6356 individuals from 3178 sibling pairs were
included in the analysis. Rural dwellers were younger,
more likely to be male and had a better cardio-metabolic
profile (Table 1). We successfully genotyped eight SNPs
arising from distinct loci which are known to be asso-
ciated with key lipid traits including total cholesterol,
LDL-cholesterol, HDL-cholesterol, and triglycerides, and
were also known to carry rare mutations associated with
Mendelian abnormalities of lipid metabolism. Minor al-
lele frequencies for the eight SNPs ranged from 7-21%
and call rates were greater than 95%. Duplicate error
rates were less than 3%. One SNP rs4420638 at the
APOE/C1/C4 locus failed HWE in the Hyderabad sam-
ples (p=3 x 10-4) and was excluded from analysis.
Association of seven SNPs with various lipid traits
Out of the seven SNPs which passed quality control, two
variants, rs562338 (APOB) and rs6511720 (LDLR)) were
previously demonstrated to be associated with LDL-
cholesterol levels; two SNPs, rs1864163 (CETP) and
rs4775041 (LIPC)) as associated with HDL-cholesterol
levels and three polymorphisms rs780094 (GCKR),
rs10503669 (LPL) and rs662799 (APOA5) as associated
with triglyceride levels in European populations [4],
[9,10]. In our analysis, we found corresponding associa-
tions for two SNPs with HDL and LDL-cholesterol
levels. We replicated one (APOB) of the two tested asso-
ciations with LDL-cholesterol as a primary trait (Table 2).
Of the two primary trait associations tested with HDL-
cholesterol at the CETP and LIPC loci, we replicated the
Table 1 Characteristics of the sib-pairs from the Indian Migration Study
Study traits Indian Migration Study (IMS)
Urban dwellers Rural dwellers P-value All participants
Sample Size 4032 2324 6356
Men (%) 52.6% 66.3% <0.0001§ 57.6%
Age (Years) 41.5 (9.4)* 39.9 (11.5) <0.0001|| 40.8 (10.3)
Body Mass Index (kg/m2) 24.9 (4.4) 22.0 (4.1) <0.0001|| 23.4 (1.21)
Triglycerides‡ 137.5 (71.3) 128.2 (64.6) <0.0001|| 134.1 (69.1)
Total Cholesterol‡ 186.5 (44.8) 177.5 (44.9) <0.0001|| 183.2 (45.1)
HDL-cholesterol‡ 43.8 (9.4) 43.0 (9.4) 0.003 43.5 (9.5)
LDL-cholesterol‡ 114.8 (39.1) 110.5 (69.6) <0.0001|| 113.2 (52.4)
Hypertension† 18.8% 16.9% <0.0001§ 18.1%
Data presented as mean (SD); *SD: Standard deviation; †Hypertension was defined using cut-off of Systolic Blood Pressure ≥140 mm of Hg and Diastolic Blood
Pressure ≥90 mm of Hg; ‡All values presented in mg/dl; §p-value from a χ2 test and ||p-value form a test for trend.
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Table 2 Within sib pair association statistics for seven SNPs with various lipid traits
Gene Reference
for test SNP
Effect Size
from European
GWAS
SNP (Minor
allele frequency)
Phenotype
associated
with test
SNP in previous
GWAS
Triglyceride Total
Cholesterol
HDL-cholesterol LDL-cholesterol
APOA5 [10] 16.88 mg/dl [10] rs662799 (G=0.19) Triglyceride 0.18
(0.11, 0.25, p=1.97 x 10-7)
0.08
(0.02, 0.14, p=0.01)
−0.04
(−0.10, 0.02, p=0.21)
0.05
(−0.01, 0.12, p=0.12)
APOB [9] 4.89 mg/dl [9] rs562338 (A=0.13) LDL-Cholesterol −0.006
(−0.09, 0.07, p=0.87)
−0.08
(−0.15, -0.002, p=0.04)
0.03
(−0.04, 0.10, p=0.44)
−0.09
(−0.17, -0.01, p=0.03)
CETP [10] 4.12 mg/dl [10] rs1864163 (A=0.20) HDL-Cholesterol −0.004
(−0.07, 0.07 , p=0.90)
−0.05
(−0.12, 0.01, p=0.12)
−0.01
(−0.08, 0.05, p=0.65)
−0.05
(−0.11, 0.02, p=0.18)
GCKR [10] 8.59 mg/dl [10] rs780094 (T=0.21) Triglyceride 0.11
(0.05, 0.18, p=0.001)
0.11
(0.05, 0.17, p=3.9x10-4)
0.04
(−0.01, 0.10, p=0.15)
0.07
(0.004, 0.13, p=0.03)
LDLR [4] −6.99 mg/d [4] rs6511720 (T=0.07) LDL-Cholesterol 0.005
(−0.11, 0.012, p=0.93)
−0.06
(−0.17, 0.05, p=0.28)
0.04
(−0.06, 0.15, p=0.39)
−0.06
(−0.18, 0.04, p=0.24)
LIPC [10] 1.38 mg/dl [10] rs4775041 (C=0.21) HDL-Cholesterol 0.03
(−0.04, 0.10, p=0.40)
0.006
(−0.05, 0.07, p=0.84)
0.08
(0.02, 0.14, p=0.007)
−0.03
(−0.09, 0.03, p=0.35)
LPL [10] 2.09 mg/dl [10] rs10503669 (A=0.12) Triglyceride −0.18
(−0.26, -0.09, p=1.0 x 10-4)
−0.09
(−0.17, 0.007, p=0.03)
0.03
(−0.05, 0.11, p=0.42)
−0.04
(−0.12, 0.04, p=0.36)
Data presented as β specific for z-scores with 95% CI and p-value.
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genetic effect at the LIPC locus. We replicated all three
tested primary trait associations with triglyceride levels.
The p-values for these associations ranged from 0.03 to
1.97 x 10-7 and the proportion of variation explained by
these SNPs ranged from 0.001 to 0.01. Briefly, we identi-
fied that the risk allele in rs562338 at APOB locus pre-
dicted 4.7 mg/dl lower LDL-cholesterol levels (95% CI:
0.52, 8.9 mg/dl, p=0.03), rs4775041 at LIPC locus asso-
ciated with 2.6 mg/dl higher HDL-cholesterol levels
(95% CI: 0.19, 1.33 mg/dl, p=0.007), rs780094 at GCKR
altered higher triglyceride levels by 7.6 mg/dl (95% CI:
3.4, 12.4 mg/dl, p=0.001), rs10503669 at LPL locus was
marked by 12.4 mg/dl lower triglyceride levels (95% CI:
6.2, 17.9 mg/dl, p=1.0 x 10-4) and rs662799 at APOA5 is
associated with 12.4 mg/dl higher triglyceride levels
(95% CI: 7.6, 17.3 mg/dl, p=1.97 x 10-7).
Association tests for SNPs at seven loci with secondary
lipid measures
Apart from association of seven SNPs with the lead lipid
traits identified in the European populations, we also
analyzed their influence on secondary lipid traits. Unlike
association tests with lead traits, this exploratory analysis
was more susceptible to type-1 error given the greater
number of null hypotheses, which were tested. In our
screen for secondary associations, we identified five
associations at p≤0.05 (Table 2). Based on a Bonferroni
correction for 21 tests (p≤0.002), a variant at the GCKR
locus (rs780094) was associated with higher total choles-
terol levels (beta=0.11 [0.05, 0.17], p=3.9x10-4), which
remained even after adjusting for body mass index
(BMI), hypertension and fasting glucose levels (β=0.11,
p=3.5 x 10-4).
Association of lipid associated SNPs with secondary
cardiovascular risk factor measures
In Table 3, we describe results from an association
screen of seven SNPs with hypertension, systolic blood
pressure, diastolic blood pressure, fasting glucose, fasting
insulin and BMI which are established risk factors for
cardiovascular diseases. We identified two associations
with hypertension, of which the strongest was at the
LDLR locus with individuals carrying the minor allele of
the variant rs6511720 having higher risk of hypertension
(OR=1.88 [1.23 - 2.88], p=0.003). This SNP was not
observed to be associated with any of the cardiovascular
traits. Including the lipid traits or obesity (BMI) as cov-
ariates did not influence the strength of association. The
minor allele at the LPL locus was associated with lower
triglyceride and total cholesterol levels (Table 2) and was
further observed to lower systolic blood pressure, fasting
glucose levels and fasting insulin levels (Table 3). The
GCKR variant associated with multiple lipid phenotypes
was also observed to increase the risk of hypertension
(OR=1.26 [1.00, 1.59] p= 0.05). None of the associations
with secondary traits survived the Bonferroni correction
based on the number of tests reported in Table 3
(pcorr=0.002). Apart from lipid traits previous results
from European studies have established the rs6511720
variant at the LDLR locus as also associated with carotid
intima media thickness, plaque and CAD [11]. Other
associations which need to be followed up in future
studies include the LPL and GCKR loci. Although the
associations of the LPL variant with systolic blood pres-
sure, fasting glucose and fasting insulin and that of the
GCKR variant with hypertension did not remain statisti-
cally robust following multiple hypothesis test correc-
tion, each of these loci were associated with multiple
traits in an independent manner suggesting pleiotropic
effects which can only be established by further studies.
The studied variant at the LPL locus was also associated
total cholesterol levels, however an association with
HDL-Cholesterol as observed in the original European
GWAS and meta-analysis was not seen [10]. The GCKR
variant demonstrated strong associations with total-
cholesterol and triglyceride levels and nominal associa-
tions with hypertension and LDL-Cholesterol, however
previous reports of associations with fasting glucose
levels [12] were not confirmed in this study.
Comparison of linkage disequilibrium patterns between
Indian and European HapMap samples
Extreme variation in LD correlations across European
and Indian populations can lead to a dilution of genetic
effects due to a breakdown in LD correlation structure.
Using HapMap-CEPH and HapMap-GIH data we did
not observe large differences in LD correlation matrices
at the seven loci between the two populations after cor-
rection for multiple tests (Table 4). The smallest empir-
ical p-value was observed at the APOA5 locus (p=0.04).
Thus, replication of five of the seven lipid SNP effects
could be due to conservation of linkage disequilibrium
structure across these loci, and that the non-replication
of the remaining two SNPs cannot be explained by sys-
tematic differences in LD, although it remains possible
that the pair wise LD between the SNPs studied and the
unknown causal variant may differ between populations.
Analysis of demographic and dietary factors as potential
effect modifiers
We tested for effect modification by sex, dietary fat in-
take and location in relation to lipid trait levels while
allowing for main effects of the five SNPs which were
associated with lipid traits. Results for this analysis are
presented in Table 5, 6 and 7. None of five tested SNPs
had any modifying effect on the genetic effect on any
lipid trait. The only gene-environment interaction term
that was of interest was at the LDLR where the effect of
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Table 3 Association of lipid associated SNPs with hypertension and diabetes related traits based on minor allele and within sib pair association estimates
from the Fulker model
Gene SNP Hypertension Systolic blood
pressure
Diastolic blood
pressure
Fasting
glucose
Fasting
insulin
BMI
APOA5 rs662799 0.84(0.65, 1.08), 0.18 −0.02(−0.09, 0.04), 0.51 −0.002(−0.07, 0.06), 0.12 −0.014(−0.08, 0.05), 0.67 0.04(−0.02, 0.11), 0.20 0.014(−0.05, 0.08), 0.63
APOB rs562338 0.79(0.58, 1.06), 0.12 −0.05(−0.13, 0.02), 0.17 −0.03(−0.11, -0.05), 0.45 −0.02(−0.10, 0.05), 0.53 0.01(−0.07, 0.09), 0.74 0.02(−0.05, 0.10), 0.49
CETP rs1864163 1.02(0.79, 1.31), 0.85 −0.03(−0.09, 0.03), 0.36 −0.03(−0.10, 0.03), 0.35 0.02(−0.04, 0.09), 0.49 0.009(−0.06, 0.08), 0.81 0.03(−0.03, 0.09), 0.40
GCKR rs780094 1.26(1.00, 1.59), 0.05 0.02(−0.04, 0.08), 0.46 0.04(−0.02, 0.10), 0.22 −0.01(−0.08, 0.05), 0.63 0.06( −0.003, 0.13), 0.06 −0.004(−0.06, 0.05), 0.88
LDLR rs6511720 1.88(1.23, 2.88), 0.003 0.06(−0.05, 0.17), 0.28 −0.01(−0.12, 0.10), 0.82 0.02(−0.09, 0.13), 0.73 −0.08(−0.19, 0.04), 0.19 −0.01(−0.11, 0.09), 0.84
LIPC rs4775041 0.98(0.78, 1.22), 0.83 −0.004(−0.07, 0.06), 0.9 −0.01(−0.08, 0.05), 0.65 −0.009(−0.07, 0.05), 0.79 0.03(−0.04, 0.09), 0.43 −0.02(−0.08, 0.03), 0.42
LPL rs10503669 0.74(0.54, 1.02), 0.07 −0.09(−0.17, -0.005), 0.04 −0.04(−0.13, 0.04), 0.35 −0.10(−0.18, -0.01), 0.02 −0.11(−0.19, -0.02), 0.02 −0.04(−0.12, 0.03), 0.28
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LDLR locus on LDL-Cholesterol was dependent on sex
(β=0.27 [0.01, 0.52], p=0.04). However, the present study
was underpowered to detect modest gene-environment
interaction effect sizes and this finding is likely due to
the play of chance. To further explore differences in ef-
fect sizes, we performed stratified analysis to estimate
SNP effect sizes based on sex, dietary fat intake and lo-
cation. Here we observed variation in regression coeffi-
cients between males and females in relation to the
strength of primary trait associations at the APOB, LDLR
and LIPC loci (Table 5). Similarly fluctuations in regres-
sion coefficients were observed with respect to predic-
tion of HDL-Cholesterol levels between urban 0.05
(−0.04, 0.13, p=0.29) and rural locations 0.17 (0.04, 0.29,
p=0.007) by the LIPC locus variant, and the prediction
of LDL-cholesterol levels between participants accus-
tomed to low fat 0.02 (−0.15, 0.20, p=0.77) or high fat
diet −0.20 (−0.36, -0.04, p=0.02) by the LDLR locus vari-
ant (Table 7). Given that these associations are not cor-
rected for multiple hypotheses testing, it is likely that
they are chance findings and require replication in well-
powered South Asian studies.
Discussion
We aimed to replicate association of eight previously iden-
tified lipid associated loci. After quality control checks, we
tested for associations of seven SNPs in distinct loci with
lipid traits. We identified associations for five of the seven
tested SNP associations and found the direction of associ-
ation for the two remaining SNPs to be consistent with
previous findings in the European population.
As variation in key lipid traits can be a result of gen-
etic variants and lifestyle related factors, it is important
to identify and characterize the proportion of variation
that can be attributed to genetic factors alone. Few gen-
etic association studies in relation to lipid traits in South
Asian populations have been published recently. Kooner
et al. [13] performed a GWAS in 1,006 Indian Asians
from the LOLIPOP study and identified variants in the
APOA1-APOC3-APOA4-APOA5 and the MLXIPL as
associated with triglyceride levels. Two further studies
attempted replication of European GWAS findings using
the same cohort of 9000 south Asian individuals [4,14].
While Teslovich et al. identified majority of association
signals in South Asians as being in the same direction as
in European population (4), Kooner et al. replicated 3
out of 8 associations they had initially identified in their
primary GWAS analysis among individuals of European
ancestry. Another study in a South Indian population
identified variants in the LPL gene to be associated with
HDL-cholesterol and hypertriglyceridemia [15].
The strongest finding in our association screen for pri-
mary traits was observed at the APOA5 locus where the
minor allele at the rs662799 variant was associated with
higher triglyceride levels. This is consistent with earlier
studies on Indian subjects from Pune and New Delhi
Table 4 Summary of Zaykin’s z2 statistic based on LD correlation structures in HapMap CEU and GIH populations
SNP (Gene) Number of SNPs in
the LD comparison
matrix
Number of z2 values in
random permutations
greater than observed z2
value
Number of z2 values
in random permutations
lower than observed z2
value
Empirical p-value
(one-sided test for
difference in LD)
rs662799 (APOA5) 25 4302 95699 0.04
rs562338 (APOB) 14 26258 73743 0.26
rs1864163 (CETP) 30 23107 76894 0.23
rs780094 (GCKR) 13 27258 72743 0.27
rs6511720 (LDLR) 6 17146 82855 0.17
rs4775041 (LIPC) 40 41804 58917 0.41
rs10503669 (LPL) 36 36613 63388 0.37
Table 5 Within sib pair association statistics for seven SNPs with lead lipid traits after stratifying for Sex
Gene Trait tested Males Females Interaction effect
APOA5 Triglycerides 0.19 (0.09, 0.29, p=0.0002) 0.17 (0.07, 0.27, p=0.001) 0.10 (−0.04, 0.25, p=0.16)
APOB LDL-Cholesterol −0.01 (−0.13, 0.10, p=0.79) −0.19 (−0.32, -0.06, p=0.005) −0.17 (−0.35, 0.01), p=0.07
CETP HDL-Cholesterol −0.02 (−0.11, 0.07, p=0.63) 0.01 (−0.09, 0.12, p=0.79) 0.03 (−0.11, 0.18, p=0.66)
GCKR Triglycerides 0.09 (−0.006, 0.18, p=0.07) 0.13 (0.03, 0.23, p=0.009) 0.06 (−0.09, 0.21, p=0.42)
LDLR LDL-Cholesterol −0.18 (−0.33, -0.02, p=0.02) 0.10 (−0.09, 0.28, p=0.30) 0.27 (0.01, 0.52, p=0.04)
LIPC HDL-Cholesterol 0.04 (−0.04, 0.12, p=0.36) 0.13 (0.02, 0.23, p=0.01) 0.09 (−0.05, 0.23, p=0.21)
LPL Triglycerides −0.14 (−0.27, -0.01, p=0.03) −0.21 (−0.34, -0.08, p=0.001) −0.06 (−0.26, 0.13, p=0.54)
Data presented as β specific for z-scores with 95% CI and p-value.
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[16,17]. The effect size observed in this study was equiva-
lent to an increase in triglyceride levels of 12.4 mg/dl (per
allele effect size= 0.18 s.d units (0.11, 0.25)) per minor al-
lele at the rs662799 variant which is lower than the pre-
dicted 16.88 mg/dl increase as published by Willer et al.
[10] for the same SNP in their South Asian samples.
The rs780094 variant in the GCKR predicted higher
triglyceride and total cholesterol levels. The associ-
ation of GCKR locus with total cholesterol levels was
the only secondary trait association that remained
associated after Bonferroni correction. This variant
has previously been described to be in strong LD
with a non-synonymous variant rs1260326 (Pro446-
Leu) [12] (r2=0.89 and 0.96 in HapMap-CEPH and
HapMap-GIH samples respectively).
Further associations which were replicated included a
SNP (rs4775041), 49 kb upstream of the LIPC gene and
the major “C” allele at this variant has previously been
shown to be associated with 1.38 mg/dl increase in HDL-
C levels [10]. In contrast, we observed the “C” allele as the
minor allele that predicted an increase in HDL-C levels
equivalent to 0.76 mg/dl ((per allele effect size= 0.08 s.d
units (0.02, 0.14)) per copy of the “C”-allele. The
rs10503669 variant at the LPL locus was previously shown
to be associated with 11.57 mg/dl increase in triglyceride
levels per copy of the common “C” allele [10]. In addition,
this variant was also associated with HDL-cholesterol
levels. We observed the minor “A” allele at this variant to
be associated with 12.44 mg/dl (per allele effect size=
−0.18 s.d units (−0.26, -0.09)) lower triglyceride levels and
4.06 mg/dl (per allele effect size= −0.09 s.d units (−0.17,
0.0007)) lower total cholesterol levels.
The genotyped variant at the LDLR locus (rs6511720)
is strongly associated with cholesterol levels [18,4] in
European populations, but we could not identify associ-
ation of this locus with either total cholesterol or LDL
and HDL- cholesterol levels. This could be because of
insufficient statistical power to detect a potentially
weaker effect in Indian population. Variants at the LDLR
gene were not studied in South Asian samples from the
LOLIPOP study as part of the Global lipid genetics con-
sortium hence comparable results are not available 4. Fu-
ture studies in South Asian populations will need to
explore whether a different variant and haplotype than
the one observed in Europeans is associated with LDL-
Cholesterol levels. The other genetic association we
failed to replicate was observed at the CETP locus. Al-
though a rcent replication study (~20,000) which fol-
lowed the Global lipid genetics consortium project too
failed to replicate the association of rs1864163 variant at
CETP with HDL-cholesterol in European Americans
[19], insufficient sample size in our analysis is the likely
explanation for the non-replication at this locus.
In an exploratory analysis, we studied whether the seven
SNPs included in the association screen for primary lipid
traits were also associated with hypertension and blood
pressure. We identified an association between LDLR vari-
ant and increased risk of hypertension, which was not
influenced by adjusting for lipid traits and obesity para-
meters. The same variant at the LDLR locus has previously
Table 6 Within sib pair association statistics for seven SNPs with lead lipid traits after stratifying for location
Gene Trait tested Urban Rural Interaction effect
APOA5 Triglycerides 0.18 (0.09, 0.27, p=0.0001) 0.19 (0.06, 0.32, p=0.004) −0.009 (−0.18, 0.16, p=0.91)
APOB LDL-Cholesterol −0.04 (−0.20, 0.12, p=0.63) −0.11 (−0.22, -0.005, p=0.34 −0.06 (−0.26, 0.13, p=0.53)
CETP HDL-Cholesterol −0.02 (−0.16, 0.22, p=0.78) −0.005 (−0.09, 0.08, p=0.90) 0.04 (−0.13, 0.21, p=0.64)
GCKR Triglycerides 0.11 (0.03, 0.20, p=0.009) 0.14 (0.01, 0.26, p=0.03) −0.004 (−0.16, 0.15, p=0.96)
LDLR LDL-Cholesterol −0.05 (−0.20, 0.09, p=0.47) −0.13 (−0.36, 0.10, p=0.26) 0.04 (−0.13, 0.21, p=0.64)
LIPC HDL-Cholesterol 0.05 (−0.04, 0.13, p=0.29) 0.17 (0.04, 0.29, p=0.007) −0.11 (−0.27, 0.05, p=0.18)
LPL Triglycerides −0.21 (−0.32, -0.09, p=0.001) −0.14 (−0.30, 0.02, p=0.09) −0.07 (−0.28, 0.14, p=0.50)
Data presented as β specific for z-scores with 95% CI and p-value.
Table 7 Within sib pair association statistics for seven SNPs with lead lipid traits after stratifying for fat intake
Gene Trait tested Low fat intake Medium fat intake Interaction effect
APOA5 Triglycerides 0.18 (0.08, 0.29, p=3.4 x 10-4) 0.19 (0.08, 0.29, p=0.001) 0.04 (−0.10, 0.19, p=0.55)
APOB LDL-Cholesterol −0.11 (−0.23, 0.02, p=0.09) −0.07 (−0.18, 0.04, p=0.21) 0.06 (−0.12, 0.23, p=0.53)
CETP HDL-Cholesterol 0.01 (−0.08, 0.11, p=0.78) −0.03 (−0.13, 0.07, p=0.61) −0.03 (−0.18, 0.11, p=0.63)
GCKR Triglycerides 0.11 (0.02, 0.21, p=0.02) 0.13 (0.03, 0.23, p=0.01) −0.03 (−0.17, 0.11, p=0.69)
LDLR LDL-Cholesterol 0.02 (−0.15, 0.20, p=0.77) −0.20 (−0.36, -0.04, p=0.02) −0.03 (−0.18, 0.11, p=0.63)
LIPC HDL-Cholesterol 0.09 (−0.004, 0.18, p=0.06) 0.09 (−0.004, 0.19, p=0.06) 0.05 (−0.09, 0.19, p=0.48)
LPL Triglycerides −0.14 (−0.27, -0.004, p=0.04) −0.21 (−0.34, -0.07, p=0.002) −0.01 (−0.20, 0.17, p=0.87)
Data presented as β specific for z-scores with 95% CI and p-value.
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been shown to be associated with myocardial infarction
and Apo B/A1 ratio [20]. Further it was shown that adjust-
ing for Apo B/A1 ratio rendered the association with myo-
cardial infarction statistically null. The rs10503669 variant
at the LPL locus, was observed to be associated with total
cholesterol levels and systolic blood pressure. A different
variant rs12678919 in complete LD with rs10503669
(r2=1) was found to be associated with triglyceride and
cholesterol levels in the south Asian samples in the LOLI-
POP study. In this study, we have replicated these genetic
effects at the LPL locus. The statistical evidence is lacking
as neither of these two secondary associations survive a
correction for multiple testing. Further investigations in
larger sample sizes in the south Asian populations should
be encouraged given the prior evidence from GWAS stud-
ies at the LDLR locus and the biological candidacy of the
LPL locus.
Associations with primary lipid traits identified in this
study include strong biological candidates with convin-
cing statistical evidence for association from previous
studies. APOA5 and APOB are apolipoproteins involved
in transport of lipids; LPL and LIPC are lipases and
GCKR actively manipulates glucose and triglyceride con-
centrations through its role in the GCKR-pathway [12].
Future studies will need to explore several common var-
iants which have subsequently been identified to be
associated with blood lipid traits [4]. In conclusion, we
have successfully replicated five of the seven established
associations between SNPs and lipid traits in the largest
replication study in an indigenous Indian population
sample. The similarity of LD correlation structures
across the European and Indian populations supports
our results and suggests conservation of genetic roles
across ethnicity and varying environmental conditions.
Methods
Study population
Phenotypic information was available on 7068 partici-
pants from the Indian Migration Study, of whom 6774
individuals were full sibling pairs. Genetic and pheno-
typic information from 3178 sib-pairs was used for asso-
ciation analysis. IMS was conducted as part of a
Cardiovascular Disease Risk Factor Screening frame-
work and participants were recruited from industrial
areas in 4 different cities (Lucknow, Nagpur, Bangalore
and Hyderabad) [21]. Factory workers and their co-
resident spouses were recruited if they were rural–
urban migrants. Each migrant worker and spouse was
asked to invite one non-migrant full sibling of the same
sex and closest to them in age and still residing in their
rural place of origin [22]. Ethical approval was obtained
from the ethics committee of the All India Institute of
Medical Sciences, New Delhi, India (AIIMS; reference
number A-60/4/8/2004).
Biochemical phenotypes
After the separation of plasma & serum, samples were
transported monthly to AIIMS, New Delhi, for biochem-
ical assays. Serum HDL-Cholesterol was estimated directly
by an elimination method [23], total cholesterol by an en-
zymatic endpoint method, and triglycerides by GPO-PAP
method using kits from Randox Laboratory Ltd. (Crumlin
City, United Kingdom). Low density lipoprotein choles-
terol level was estimated using the Friedewald-Fredrickson
formula [24]. The quality of local assays was cross-
checked with regular external standards and internal
duplicate assays and monitored by AIIMS. For quality as-
surance the Cardiac Biochemistry Lab, AIIMS, is part of
the UK National External Quality Assessment (http://
www.ukneqas.org.uk/). Hypertension was defined as either
a systolic blood pressure ≥140 mmHg or a diastolic blood
pressure ≥90 mmHg [25]. Fasting plasma glucose was
measured on the day of blood collection by local labora-
tories at each site using the GOD-PAP method and RAN-
DOX kits (Randox Laboratories, Crumlin, UK) [26].
Fasting insulin was assayed in serum samples by the ELISA
method, as a solid-phase two-site enzyme immunoassay,
using kits from MERCODIA (Mercodia AB, Sylveniusgatan,
Uppsala, Sweden) [27]. Body mass index was calculated
as weight in kilograms divided by the squared product of
height measured in metres.
SNP selection and genotyping
The eight lipid associated SNPs were genotyped in paral-
lel with 51 other SNPs reported to be associated with
type-2 diabetes, obesity, myocardial infarction and height
at the time of inception of this study in 2008. The choice
of SNPs was restricted to those variants which were
associated with lipid trait/traits at genome wide levels of
significance in European studies and were also biologic-
ally plausible given their location in genes known to be
linked with Mendelian abnormalities of lipid metabol-
ism. The selected loci are strong biological candidates
given that rare mutations in seven of them (excluding
GCKR) have been observed in Mendelian abnormalities
of lipid metabolism. These abnormalities include hyper-
triglyceridemia [28,29], familial hypercholesterolemia
[30,31], complete hepatic lipase (HL) deficiency [32],
type I hyperlipidemia [33] and Familial dysbetalipopro-
teinemia [34]. Hence a further aim of this study was to
assess the role of common variants in genes which are
linked with rare forms of Mendelian abnormalities of
lipid metabolism in regulating lipid levels on a popula-
tion level. We included the GCKR locus in the Genomic
DNA samples already stored in 96 deep well storage
plates at a uniform concentration of 10ng/λ were used
for genotyping using sequenom based Mass ARRAY
assay technology. For quality control purposes, ~10%
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(n=8) duplicates were incorporated into each of the 96
deep well storage plates.
Statistical analysis
SNP quality control and association models
Deviation from Hardy-Weinberg equilibrium (HWE)
was tested using the exact test implemented in Plink
[35] for all the 8 SNPs in unrelated IMS participants
(N=3387), while employing both overall IMS samples
and city-wise samples. Any SNP that failed HWE test
(P-value ≤0.001) in participants from any of the 4 cities
or the overall IMS sample was excluded from association
analysis. We have previously reported evidence of popu-
lation substructure within IMS with potentially up to 10
population subgroups [36].
Association analysis was performed using Fulker’s gen-
etic association model which decomposes genotypes into
between and within sib-pair association effects [37].
Both these effects were modeled independently and
inferences were drawn based on the within sib-pair com-
ponent which is unaffected by population substructure.
Linear mixed effect regression models were used for as-
sociation analysis. The main effect model included the
lipid trait as the dependent variable and between and
within sib-pair coding of the test SNP as explanatory
variables. The lipid trait marked as the lead trait for each
SNP was based on its association at genome wide signifi-
cance in previous GWASs and subsequent replication in
independent studies. Lipid phenotypes other than the
lead traits were described as secondary traits. Standar-
dized z-scores of lead and secondary traits were used as
the dependent variables.
Covariates included age, sex, location (urban or rural)
and city. A random sib-pair effect was included to allow
for shared environmental and polygenic effects. Associ-
ation analysis using mixed effect models was implemen-
ted using STATA v11.2 (Stata corp, Texas, USA) and
UNPHASED [38]. Percentage of variance explained by
the test SNPs was measured by calculating the additive
genetic variation for each of the test SNP and dividing
this value by the total phenotypic variance for the lipid
trait being studied. Additive genetic variance was esti-
mated as Va= 2pq β2, where β is the regression coeffi-
cient of the within sib-pair component of Fulker’s genetic
association model and p and q are the allele frequencies
for the major and minor alleles. This estimate of additive
genetic variation is based on the classical formula used for
non-familial genotype data where Va = (2pq[p(X11 −X12)
+ q(X12–X22)]
2) [39] and X11, X12 and X22 are estimated
means of lipid traits for common allele homozygotes, het-
erozygotes and rare allele homozygotes respectively.
For stratified analysis dietary fat intake was defined by a
binary variable which grouped individuals as low and high
fat intake after defining the median as the cut-off point.
Fat intake was assessed by an interviewer-administered
semi-quantitative food frequency questionnaire (FFQ).
Gene-Environment (Diet, Location and Sex) interaction
effects were tested while including Gene-Environment
interaction terms within the fixed effects component of
Fulker’s association model.
Comparison of linkage disequilibrium (LD) correlation
patterns for lipid trait genes between HapMap-GIH and
CEPH
We used genotype data available from phase-3 of
HapMap-CEPH (Centre d'Etude du Polymorphisme
Humain) and GIH (Gujarati Indians in Houston) popu-
lations to compare the linkage disequilibrium between
the two population groups. The overall difference in
pair wise LD (r2) was calculated using the z2 statistic
of Zaykin et al. [40], which is the sum of squared
element-wise differences between two LD matrices [40].
We performed 100,000 permutations of subject ethnicity
to assess the significance of the z2 statistic under the null
hypothesis that the two populations have the same aver-
age pair-wise LD. Permutation tests were performed
using the cvpermute command in MATA in STATA
v11.2 (Stata corp, Texas, USA).
Power calculations
Given a minor allele frequency (MAF) range of 7-21%
and a sample size of 3178 sib pairs; we had over ≥80%
power to detect associations which explained ≥0.003% of
variation in the studied lipid traits. Sample size calcula-
tions were performed using the Genetic Power Calcula-
tor [41] at statistical significance of p≤0.05 since this was
a replication study. For stratified analysis in females
(42.3%), in participants from rural location (36.6%) and
in individuals on low dietary fat intake (50%), we had
≥80% power to detect effect sizes which explained
≥0.006%, ≥0.007% and ≥0.005% of variation in quantita-
tive traits.
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